Effects of ethanol-induced p42/44 MAPkinase activity on IGF system in primary cultured rat hepatocytes

흰쥐의 배양된 간세포에서 ethanol에 의해 유도된 p42/44 MAPkinase가 IGF system에 미치는 효과

  • Lee, Sun-Mi (College of Veterinary Medicine, Bio-safety Research Institute, Chonbuk National University) ;
  • Kim, Jong-Hoon (College of Veterinary Medicine, Bio-safety Research Institute, Chonbuk National University) ;
  • Kang, Chang-Won (College of Veterinary Medicine, Bio-safety Research Institute, Chonbuk National University)
  • 이선미 (전북대학교 수의과대학, 생체안전성 연구소) ;
  • 김종훈 (전북대학교 수의과대학, 생체안전성 연구소) ;
  • 강창원 (전북대학교 수의과대학, 생체안전성 연구소)
  • Accepted : 2006.12.03
  • Published : 2006.12.30


Ethanol abuse is associated with liver injury, neurotoxicity, modulation of immune responses, and increased risk for cancer, whereas moderate ethanol consumption exerts protective effects against liver injury. However, the underlying signal transduction mechanisms of insulin-like growth factors (IGFs) which play an important regulatory role in various metabolism mechanisms are not well understood. We investigated the effects of ethanol-induced p42/44 activity on IGF-I secretion, IGF-I receptor and IGFBP-1 secretion using radioimmunoassay and western blotting in primary cultured rat hepatocytes. The p42/44 activity, IGF-I secretion and IGF-I receptor activity significantly accelerated compared to control at 10 and 30 min after 200 mM ethanol treatment, but then it became suppressed at 180 min. In contrast, IGFBP-1 secretion was inhibited compared to control at 30 min after 200 mM ethanol treatment, but increased at 180 min. The IGF-I secretion, IGF-I receptor and p42/44 activity at 30 min after 200 mM ethanol treatment accelerated with increasing ethanol concentration but IGFBP-1 secretion inhibited (p<0.05). The increased IGF-I secretion, inhibited IGFBP-1 secretion and IGF-IR activity by ethanol-induced temporal p42/44 activity at 30 min after ethanol treatment was blocked by treatment with PD98059. Alcohol dehydrogenase (ADH) inhibitor, 4-methylpyramazole blocked the changes of IGF-I secretion, IGFBP-1 secretion, and IGF-IR activity by ethanol-induced p42/44 activity at 30 and 180 min. Taken together, these results suggest that ethanol is involved in the modulation of IGF-I and IGFBP-1 secretion and IGF-IR activity by p42/44 activity in primary cultured rat hepatocytes. In addition, changing of p42/44 activity by ethanol was caused with ADH.


Supported by : 전북대학교


  1. Aroor AR, Shukla SD. MAP Kinase signaling in diverse effects of ethanol. Life Science 2004, 74, 2339-2364 https://doi.org/10.1016/j.lfs.2003.11.001
  2. Bailey SM, Cunningham CC. Contribution of mitochodria to oxidation stress associated with alcoholic liver disease. Free Radi Biol Med 2002, 32, 11-16 https://doi.org/10.1016/S0891-5849(01)00769-9
  3. Baserga R, Rubin R. Cell cycle and growth control. Crit Rev Eukaryot Gene Expr 1993, 3, 47-61
  4. Chen J, Ishac EJ, Dent P, Kunos G, Gao B. Effects of ethanol on mitogen-activated protein kinase and stress-activated protein kinase cascades in normal and regeneratinn liver. Biochem J 1998, 334(Pt3), 669-676 https://doi.org/10.1042/bj3340669
  5. Conover CA. Regulation and physiological role of insulin-like growth factor binding proteins. Endocr J 1996, 43, 38-48
  6. Crabb DW, Bosron WF, Li TK. Ethanol metabolism. Pharmacol Ther 1987, 34, 59-73 https://doi.org/10.1016/0163-7258(87)90092-1
  7. D'Ercole AJ, Stiles AD, Louis EU. Tissue concentrations of somatomedicin C : Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci 1984, 81, 935-939 https://doi.org/10.1073/pnas.81.3.935
  8. Domeniccotti C, Paola D, Vitali A, Nitti M, Cottalasso D, Melloni E, Poli G, Marinari UM, Pronzato MA. Mechanisms of inactivation of hepatocyte protein kinase C isoforms following acute ethanol treatment. Free Radical Biol Medi 1998, 25, 529-535 https://doi.org/10.1016/S0891-5849(98)00079-3
  9. Froesch ER, Schmid C, Schwander J, Zapf J. Actions of insulin-like growth factors. Ann Rev Physiol 1985, 47, 443-67 https://doi.org/10.1146/annurev.ph.47.030185.002303
  10. Hidiroglou N, Madere R. Effect of chronic ethanol dosing on hepatic triglyceride and phospholipid profile and fatty acid in the guinea pig. Alcohol 1999, 19, 229-233 https://doi.org/10.1016/S0741-8329(99)00051-8
  11. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins:Biological Actions. Endocrine Review 1995, 16, 3-34
  12. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 2003, 13, 113-170 https://doi.org/10.1016/S1096-6374(03)00038-8
  13. Kundu AK, Nagaoka M, Chowdhury EH, Hirose S, Sasagawa T, Akaike T. IGF-I induces growth, survival and morphological chage of primary hepatocytes on a galactose-bared polymer through both MAPK and $\beta$- catemin pathways. Cell Struct Funct 2003, 28, 255-263 https://doi.org/10.1247/csf.28.255
  14. Kurose I, Higuchi H, Miura S, Saito H, Watanabe N, Hokari R, Hirokawa M, Takaishi M, Zeki S, Nakamura T, Ebinuma H, Kato S, Ishii H. Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication. Hepatology 1997, 25, 368-378 https://doi.org/10.1002/hep.510250219
  15. Lee PD, Giudice LC, Conover C, Powell DR. Insulin-like growth factor-binding protein-I : recent findings and new directions. Proc Soc Exp Biol Med 1997, 216, 319-357 https://doi.org/10.3181/00379727-216-44182
  16. Lee SM, Kang CW. Effects of ethanol on secretion of insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-1 (IGBP-1) in primary rat hepatocytes: Involvement of lipid peroxidase (LPO) activity. Korean J Lab Anim Sci 2004, 20, 391-397
  17. Lee YJ, Aroor AR, Shukla SD. Temporal activation of p42/44 mitogen-activated protein kinase and c-Jun N-terminal kinase by acetaldehyde in rat hepatocytes and its loss after chronic ethanol exposure. J Pharmacol Exp Ther 2002, 301, 908-914 https://doi.org/10.1124/jpet.301.3.908
  18. Lee YJ, Shukla SD. Pro- and anti-apoptotic roles of c-Jun N-terminal kinase (JNK) in ethanol and acetaldehyde exposed rat hepatocytes. Eur J Pharmacol 2005, 508, 31-45 https://doi.org/10.1016/j.ejphar.2004.12.006
  19. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995, 16, 143-163 https://doi.org/10.1210/edrv-16-2-143
  20. Lieber CS. Mechanism of ethanol induced hepatic injury. Pharmacol Ther 1990, 46, 1-41 https://doi.org/10.1016/0163-7258(90)90032-W
  21. Lieber CS. Metabolism of alcohol. Clin Liver Dis 2005, 9, 1-35 https://doi.org/10.1016/j.cld.2004.10.005
  22. Miller RA, Buehner G, Chang Y, Harper JM, Sigler R, Smith-Wheelock M. Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance. Aging Cell 2005, 4, 119-125 https://doi.org/10.1111/j.1474-9726.2005.00152.x
  23. Nomura F, Pikkarainen PH, Jauhonen P, Arai M, Gordon ER, Baraona E, Lieber CS. Effect of ethanol administration on the metabolism of ethanol in baboons. J Pharmacol Exp Ther 1983, 227, 78-83
  24. Park SH, Heo JS, Kang CW. Dose-dependent effect of alcohol on insulin-like growth factor systems in male rats. Clin Exp Pharmacol Physiol 2004, 31, 22-28 https://doi.org/10.1111/j.1440-1681.2004.03945.x
  25. Perks CM, Newcomb PV, Norman MR, Holly JM. Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells. J Mol Endocrinol 1999, 22, 141-150 https://doi.org/10.1677/jme.0.0220141
  26. Pezzarossa A, Dazzi D, Negro R, Cervigni C, Vescovi PP. Effects of alcohol consumption and accompanying diet on metabolic response to arginine in chronic alcoholics. J Stud Alcohol 1999, 60, 581-585 https://doi.org/10.15288/jsa.1999.60.581
  27. Potter JJ, MacDougald OA, Mezey E, Regulation of rat alcohol dehydrogenase by cyclic AMP in primary hepatocyte culture. Arch Biochem Biophys 1995, 321, 329-335 https://doi.org/10.1006/abbi.1995.1402
  28. Reddy MM, Shukla SD. Potentiation of mitogenactivated protein kinase by ethanol in embryonic liver cells. Biochem Pharmacol 1996, 51, 661-668 https://doi.org/10.1016/S0006-2952(95)02239-2
  29. Seglen PO. Preparation of isolated liver cells. Methods Cell Biol 1975, 13, 29-83
  30. Sell C, Baserga R, Rubin R. Insulin-like growth factor-I and the IGF-receptor prevent etoposide-induced apoptosis. Cancer Res 1995, 55, 303-306
  31. Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, DeAngelis T, Rubin R, Efstratiadis A, Baserga R. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryofibroblasts. Mol Cell Biol 1994, 14, 3604-3612 https://doi.org/10.1128/MCB.14.6.3604
  32. Tombes RM, Auer KL, Mikkelsen R, Valerie K, Wymann MP, Marshall CJ, McMahon M, Dent P. The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. Biochem J 1998, 330, 1451-1460 https://doi.org/10.1042/bj3301451
  33. Weng Y, Shukla SD. Ethanol alters angiotensin II stimulated mitogen activated protein kinase in hepatocytes: agonist selectivity and ethanol metabolic independence. Eur J Pharmacol 2000, 398, 323-331 https://doi.org/10.1016/S0014-2999(00)00313-7